zydus cadila

Zydus Cadila gets tentative US FDA approval for Brivaracetam tablets

Zydus Cadila has received tentative approval from the USFDA to market Brivaracetam Tablets, in the strengths of 10 mg, 25…

3 years ago

Zydus granted permission for clinical trials of antibody cocktails

New Delhi: The only Indian company Zydus Cadila which claims to have developed neutralising monoclonal antibodies (mAbs)-based cocktail for the treatment of Covid-19 has…

3 years ago

USFDA nod to Zydus for production of Fluphenazine Hydrochloride

Zydus Cadila has received final approval from the USFDA to market Fluphenazine Hydrochloride Tablets in the strengths of 1 mg,…

3 years ago

Zydus Cadila and Taiwan’s TLC to collaborate to market Black fungus drug AmphoTLC

Zydus Cadila and Taiwan-based specialty pharmaceutical firm TLC on Wednesday said they have signed a pact to market Liposomal Amphotericin…

3 years ago

Zydus seeks DCGI nod for clinical trial for monoclonal antibodies cocktail

Zydus has announced biological therapy ZRC-3308, used to treat mild COVID-19. The pharmaceutical company now seeks DCGI (Drugs Controller General…

3 years ago

Zydus launches Ujvira (trastuzumab emtansine) for breast cancer treatment

Zydus Cadila launched Trastuzumab Emtansine, an antibody-drug conjugate (ADC) biosimilar and a drug for treating both early and advanced HER2…

4 years ago

DCGI approves emergency use of Zydus’ anti-Covid drug Virafin

The Drug Controller General of India (DCGI) approved emergency use of Zydus Cadila’s anti-Covid drug ‘Virafin’ on Friday. Virafin, or…

4 years ago

Zydus gets USFDA nod to market Ibrutinib capsules 70mg

Zydus Cadila announced on Thursday that USFDA has approved it to market Ibrutinib Capsules, 70 mg and 140 mg. According…

4 years ago

Ministry of Commerce and Industry awarded Zydus Infrastructure as best performer

The Zydus Infrastructure bags awards for Best overall performer among Private SEZs , the company makes announcement by a tweet.…

4 years ago